BioXcel Therapeutics Inc logo

BioXcel Therapeutics Inc

FRA:BX2 (USA)  
€ 1.49 (-7.71%) Jun 4
At Loss
Market Cap:
€ 56.10M ($ 61.02M)
Enterprise V:
€ 81.63M ($ 88.80M)
Volume:
5.36K
Avg Vol (2M):
2.62K
Also Trade In:

BioXcel Therapeutics Inc Valuation Measures